LSS-NIPT: Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT06089746
Collaborator
(none)
20
1
1
24
0.8

Study Details

Study Description

Brief Summary

Lumbosacral spinal stenosis (LSS) is a leading cause of limited mobility, reduced independence, and poor health outcomes in older adults, and is very common in older adult Veterans. Several years ago, major research studies indicated that surgery for LSS was more effective than usual (medical) management. Nonetheless, there are many patients for whom surgery is not the ideal therapy. There have been reports that modifications in daily activities including temporary use of a modified rolling walker and changes in sleep positioning may help relieve LSS. The investigators have assembled a VA team to study this carefully. The investigators will recruit a small group of older adult Veterans with LSS to try out this program; the investigators will monitor them closely for relief of their symptoms and improvements in walking. The investigators will, as part of this small study, try to understand potential barriers to use of this therapy. The investigators will interview the Veterans and healthcare providers to identify problems that may arise in trying this therapy. If this small study works, the investigators plan to expand the effort.

Condition or Disease Intervention/Treatment Phase
  • Other: NIPT
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans (LSS-NIPT)
Anticipated Study Start Date :
Feb 15, 2024
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Feb 16, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Feasibility

Patients with LSS will receive DME and training to support continuous maintenance of flexion posture during the 6 week trial. All participants will be asked to wear actigraphs and pedometers intermittently and to complete questionnaires and mobility assessments.

Other: NIPT
Coordinated suite of DME and training to support continuous maintenance of flexion posture during the 6 week trial.

Outcome Measures

Primary Outcome Measures

  1. Change in mobility by actigraph (positive, negative, or zero) as determined by the difference in mobility at Week 6 compared to baseline [Week 6]

    Actigraph mobility

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Veterans receiving care at participating VA

  • Ability to read and write English and understand instructions

  • Agrees to comply with instructions

  • Symptoms for over 3 months

  • Diagnosis of Lumbar Spinal Stenosis as the cause of symptoms

  • Discomfort involving low back pain and / or neurogenic claudication of legs or thighs

  • Back and/or leg symptoms greater than 3/10 provoked by walking and / or standing

  • X ray, CT, or MRI performed within the last 12 months shows Lumbar Spinal Stenosis at 1 or 2 levels

  • Prior treatment for Spinal Stenosis including therapy, medication, epidural injections, but not surgery

  • Relief of pain (standardly within 5 minutes) by sitting down

  • Ability to walk 50 feet without a cane or walker

  • General health presents ability to increase activity level if Back and / or leg symptoms resolve

  • If home has stairs and patient uses multiple levels, must have steady handrail

  • Transportation routinely available by car or car service and not by bus

  • Home location allows restriction of walking to flat surfaces (lack of hills), with availability to increase ambulation on flat surfaces

Exclusion Criteria:
  • Previous Low Back Surgery for SS including decompression or fusion

  • Successful Spinal Stenosis Treatment (such as injection) over the prior 3 months

  • X ray, CT, or MRI shows Lumbar Spinal Stenosis in 3 or 4 levels

  • Prior Lumbar Fracture

  • Scoliosis with Cobb angle over 20 degrees on weight bearing AP Views

  • Inflammatory arthropathy involving the Lumbar Spine, such as RA

  • Radiculopathy attributed to herniated disc

  • Suspected or confirmed moderate to severe large fiber neuropathy

  • Failure of relief of back or leg pain brought on by standing or walking, within 5 minutes, by sitting down

  • Rapid increase in symptoms with lumbar flexion such as sitting, Increase in symptoms brought on by leaning on grocery cart or walker

  • Reduced symptoms by lumbo-sacral extension

  • Vascular Claudication with ABI less than 60 or over 140

  • Prior bypass or stent surgery for PAD

  • Current foot, ankle, leg, or thigh infection or open ulcer

  • Current use of a Brace for foot, ankle, or knee pathology,

  • Moderate to severe arthritis of the Hip, knee, ankle or foot preventing pain free ambulation greater than 1 block

  • Neurologic or neurodegenerative induced gait pathology such as CVA, Parkinson's, NPH, Cervical Myelopathy

  • Current Medico Legal issues, active substance use, SI, HI, or other factors that may interfere with completion of six-week treatment trial

  • Planned surgery or procedure in the 6-week study period

Contacts and Locations

Locations

Site City State Country Postal Code
1 Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Baltimore Maryland United States 21201

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Beth B. Hogans, MD, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT06089746
Other Study ID Numbers:
  • E4412-P
First Posted:
Oct 18, 2023
Last Update Posted:
Oct 18, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2023